Ajanta Pharma USA recalls

Ajanta Pharma USA has 3 recalls on record with the FDA and USDA, the earliest in 2026 and the latest reported on 16 Sep 2026. 3 are still ongoing. 3 were reported in the last 12 months. The most frequent reason is manufacturing (cgmp) deviations.

Total recalls3since 2026

Last 12 months3reported

Class I00% of total

Ongoing3latest 16 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 1 1Jul 0 1

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why ajanta pharma usa is recalled

Product types

Cholesterol Medication133%

Brands

By year

20263100%

Ongoing ajanta pharma usa recalls

3 active

Reported	Class	Recall	Company	Reason	Where
16 Sep 2026Drug	CLASS III	Fluphenazine Hydrochloride Tablets, USP, 1mg recalledFluphenazine Hydrochloride	Ajanta Pharma USA	Potency & Assay	Nationwide
1 Jul 2026Drug	CLASS II	Fenofibrate Capsules, USP 200 mg recalled by Ajanta Pharma USAFenofibrate	Ajanta Pharma USA	Manufacturing (CGMP) Deviations	Nationwide
24 Jun 2026Drug	CLASS II	Aripiprazole Tablets recalled by Ajanta Pharma USAAripiprazole	Ajanta Pharma USA	Packaging Defects	Nationwide

All ajanta pharma usa recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
16 Sep 2026Drug	CLASS III	Fluphenazine Hydrochloride Tablets, USP, 1mg recalledFluphenazine Hydrochloride	Ajanta Pharma USA	Potency & Assay	Nationwide
1 Jul 2026Drug	CLASS II	Fenofibrate Capsules, USP 200 mg recalled by Ajanta Pharma USAFenofibrate	Ajanta Pharma USA	Manufacturing (CGMP) Deviations	Nationwide
24 Jun 2026Drug	CLASS II	Aripiprazole Tablets recalled by Ajanta Pharma USAAripiprazole	Ajanta Pharma USA	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.